• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GNP
Click for more information
1.56% $2.53

GENUSPLUS GROUP LTD - Charts / Financials

Market Cap $449.6M  ! watchlist Created with Sketch. Add to my watchlist
Industrials Conglomerates

GenusPlus Group Ltd is an Australia-based specialist power and communications... GenusPlus Group Ltd is an Australia-based specialist power and communications infrastructure and services provider. The Company and its subsidiaries' principal activities include the construction and maintenance of transmission and distribution power lines and substations servicing the Western Australian, Queensland, New South Wales and Tasmanian power networks, as well as providing specialist engineering, testing and commissioning services to the electrical and communications industries. Its segments include Infrastructure, Communications and Industrial Services. Its Infrastructure segment offers a range of services, including planning, designing, constructing, operating, testing, maintaining, managing and decommissioning power network assets. Its Communications segment is engaged in constructing networks, to maintain and upgrade existing infrastructure. Its Industrial Services segment provides fully integrated electrical and instrumentation (E&I) and mechanical services.More

refresh Created with Sketch. REFRESH
Last update - 15.57pm 08/11/2024 (20 minute delay) ?
Day
Open $2.55   Day High $2.59   Day Low $2.48
Daily Volume 266906
Bids   Sellers
Number Price Volume   Number Price Volume
1 $2.52 120   1 $2.55 308

Data source: Refinitiv

(20min delay)
Last
$2.53 		Change
-0.040(1.56%) 		Mkt cap ! $449.6M
Open High Low Value Volume
$2.55 $2.59 $2.48 $676.3K 266.9K

Buyers (Bids)

No. Vol. Price($)
1 120 $2.52
 

Sellers (Offers)

Price($) Vol. No.
$2.55 308 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
Last
$2.53 		  Change
-0.040 ( 1.14 %)
Open High Low Volume
$2.54 $2.58 $2.47 348535
Last updated 15.57pm 08/11/2024 ?

Top Stories

Imugene kicks off Australian trial for blood cancer treatment

Imugene Ltd has opened its first Australian trial for a Phase 1b clinical trial to test CAR T cell therapy azer-cel
Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next? Trump’s pro-Bitcoin stance has fuelled optimism across the crypto landscape, which is looking ahead to a more favourable environment
Universal Biosensors flat despite fresh deal with US medical product distributor Universal Biosensors shares were flat on Friday, even as the microcap healthcare company inked a US distribution deal.
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive The Dow Jones finished up +3% on election day; the NASDAQ and S&P weren’t far behind. Gold traders aren’t sure what to do.
Trump is President Again: What Does This Mean for Crypto? Donald Trump swept the 2024 US presidential election, comprehensively beating the Democratic candidate Kamala Harris.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.